Exchange: NASDAQ·Updated 07:30 PM EDT
AVBP logo

AVBP ArriVent BioPharma Inc.

$27.97
$0.60
(2.10%)
Today
Closed $27.97
$0.00
(0.00%)
After Hours
EarningsNov 16
Mkt Cap$1.41B
Vol337,272.00

About AVBP

Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, licensing, and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.
43

Bearish Sentiment

How do you feel about AVBP?

Advertisement|Remove ads.